🇺🇸 FDA
Patent

US 11707447

C4-carbonothioate-substituted tryptamine derivatives and methods of using

granted A61KA61K31/4045A61P

Quick answer

US patent 11707447 (C4-carbonothioate-substituted tryptamine derivatives and methods of using) held by Enveric Biosciences Canada Inc. expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enveric Biosciences Canada Inc.
Grant date
Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/4045, A61P, A61P25/00